These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6249089)

  • 21. Environmental enrichment and neurotransmitter receptors.
    Por SB; Bennett EL; Bondy SC
    Behav Neural Biol; 1982 Feb; 34(2):132-40. PubMed ID: 6123308
    [No Abstract]   [Full Text] [Related]  

  • 22. The molecular architecture of ergopeptines: a basis for biological interaction.
    Weber HP
    Adv Biochem Psychopharmacol; 1980; 23():25-34. PubMed ID: 6249091
    [No Abstract]   [Full Text] [Related]  

  • 23. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
    Ase AR; Reader TA; Hen R; Descarries L
    J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands.
    el Ahmad Y; Laurent E; Maillet P; Talab A; Teste JF; Dokhan R; Tran G; Ollivier R
    J Med Chem; 1997 Mar; 40(6):952-60. PubMed ID: 9083484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Fornaretto MG; Caccia C; McArthur RA
    J Med Chem; 1996 Aug; 39(16):3195-202. PubMed ID: 8759642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotransmitter receptors in adult tottering (tg/tg) mice.
    Dusser AE; Peroutka SJ
    Epilepsia; 1990; 31(4):378-81. PubMed ID: 2164468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ergot alkaloids and central monoaminergic receptors.
    Goldstein M
    J Pharmacol; 1985; 16 Suppl 3():19-24. PubMed ID: 3005775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotransmitter receptor alterations in Alzheimer disease: a review.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1987; 1(1):9-18. PubMed ID: 2840100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug and neurotransmitter receptors in the brain.
    Snyder SH
    Science; 1984 Apr; 224(4644):22-31. PubMed ID: 6322304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental changes of some G-protein coupled receptors affected by c-fos knock-out.
    Benes J; Nováková M; Kvetnanský R; Myslivecek J
    Prague Med Rep; 2006; 107(1):61-70. PubMed ID: 16752804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminopyrimidines with high affinity for both serotonin and dopamine receptors.
    Wustrow D; Belliotti T; Glase S; Kesten SR; Johnson D; Colbry N; Rubin R; Blackburn A; Akunne H; Corbin A; Davis MD; Georgic L; Whetzel S; Zoski K; Heffner T; Pugsley T; Wise L
    J Med Chem; 1998 Feb; 41(5):760-71. PubMed ID: 9513604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical strategies for evaluating ECT mechanisms--pharmacological, biochemical and psychophysiological approaches.
    Lerer B; Sitaram N
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):309-33. PubMed ID: 6137030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography.
    Mangold C; Ksiazek I; Yun SW; Berger E; Binkert C
    Neuropeptides; 2008 Aug; 42(4):377-86. PubMed ID: 18547640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of catecholamine release by presynaptic receptor system.
    Patel S; Patel U; Vithalani D; Verma SC
    Gen Pharmacol; 1981; 12(6):405-22. PubMed ID: 6273255
    [No Abstract]   [Full Text] [Related]  

  • 36. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of ingestive behaviour.
    Samanin R; Garattini S
    Therapie; 1996; 51(2):107-15. PubMed ID: 8763044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Receptor-ligand reaction in the central nervous system (principal problems and prospects for development)].
    Korneev AIa; Mukhin AG
    Vestn Akad Med Nauk SSSR; 1981; (5):56-9. PubMed ID: 6269319
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
    Millan MJ; Maiofiss L; Cussac D; Audinot V; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2002 Nov; 303(2):791-804. PubMed ID: 12388666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple serotonin receptors and their physiological significance.
    Peroutka SJ; Snyder SH
    Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.